Application 061827
- Type
- ANDA
- Sponsor
- PHARMACIA AND UPJOHN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CLEOCIN | CLINDAMYCIN PALMITATE HYDROCHLORIDE | FOR SOLUTION;ORAL | EQ 75MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A061827-001 | CLEOCIN | CLINDAMYCIN PALMITATE HYDROCHLORIDE | EQ 75MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SOLUTION / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A061827-001 | CLEOCIN | EQ 75MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SOLUTION / ORAL | Approved before 1982 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A061827-001 | CLEOCIN | EQ 75MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SOLUTION / ORAL | Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A061827-001 | CLEOCIN | EQ 75MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SOLUTION / ORAL | Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A061827-001 | CLEOCIN | EQ 75MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | FOR SOLUTION / ORAL | Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clindamycin Palmitate Hydrochloride (Pediatric) | CLINDAMYCIN PALMITATE HYDROCHLORIDE | Amneal Pharmaceuticals of New York LLC | faf67eb8-1fd7-4b2c-a55b-24ba664c0dce | 2026-06-17 | Boxed warning, Warnings, Adverse reactions | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| Cleocin Pediatric | CLINDAMYCIN PALMITATE HYDROCHLORIDE | Pharmacia & Upjohn Company LLC | 1ef87b6c-9d32-44ac-8c55-8bf01424cc45 | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| Cleocin | CLINDAMYCIN PHOSPHATE | Pharmacia & Upjohn Company LLC | 3db26227-208d-4fdd-8426-1d9be5cda9b4 | 2026-03-09 | Warnings, Adverse reactions | Cleocin |
| Cleocin | CLINDAMYCIN PHOSPHATE | Pharmacia & Upjohn Company LLC | f9be442d-0782-4b93-828f-9ebbf67dbced | 2025-11-19 | Warnings, Adverse reactions | Cleocin |
| Clindamycin Palmitate Hydrochloride | CLINDAMYCIN PALMITATE HYDROCHLORIDE | Chartwell RX, LLC | 5d120b48-8181-4f40-a0e5-1f5cd0450d4f | 2025-09-12 | Boxed warning, Warnings, Adverse reactions | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) | CLINDAMYCIN PALMITATE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 0800afad-e4cd-4f70-aaa1-a14547be4729 | 2025-04-24 | Boxed warning, Warnings, Adverse reactions | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) | CLINDAMYCIN PALMITATE HYDROCHLORIDE | Bryant Ranch Prepack | 3afe52c2-b65b-40fe-b2fa-da39f1bcf529 | 2024-09-03 | Boxed warning, Warnings, Adverse reactions | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| CLINDAMYCIN PALMITATE HYDROCHLORIDE (Pediatric) | CLINDAMYCIN PALMITATE HYDROCHLORIDE | Bryant Ranch Prepack | 28ba03fd-0f9c-49c6-9bfb-cda5417801c6 | 2024-04-03 | Boxed warning, Warnings, Adverse reactions | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
| clindamycin palmitate hydrochloride | CLINDAMYCIN PALMITATE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | a2279019-9341-4346-8746-fea262b27dd8 | 2022-12-16 | Boxed warning, Warnings, Adverse reactions | CLINDAMYCIN PALMITATE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.